MAPT and Alzheimer disease: Given the progressive deterioration of the BBB at the MCI and AD stages (40, 41), which allows APOB and LDL-C to enter the brain (13, 39), these findings are particularly relevant to our results regarding the contribution of blood LDL-C, an acolyte of APOB, on brain tau deposition.